|
"pei jer chen"的相關文件
顯示項目 751-800 / 883 (共18頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T08:41:24Z |
Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C
|
Liu, C.-J. ;Cheng, H.-R.; Chen, C.-L.; Chen, T.-C.; Tseng, T.-C.; Wang, Z.-L. ;Chen, P.-J. ;Liu, C.-H. ;Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:41:23Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang, H.-H.;Shih, W.-L.;Li, Y.-H.;Wu, C.-F.;Chen, P.-J.;Lin, C.-L.;Liu, C.-J.;Liaw, Y.-F.;Lin, S.-M.;Lee, S.-D.;Yu, M.-W.; MING-WHEI YU; CHUN-JEN LIU; PEI-JER CHEN; WEI-LIANG SHIH |
| 臺大學術典藏 |
2018-09-10T08:41:21Z |
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
|
Chen, K.-F.;Tai, W.-T.;Huang, J.-W.;Hsu, C.-Y.;Chen, W.-L.;Cheng, A.-L.;Chen, P.-J.;Shiau, C.-W.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:38:36Z |
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
|
Liu, C.-H. ;Liang, C.-C. ;Huang, K.-W.; Liu, C.-J. ;Chen, S.-I.; Lin, J.-W. ;Hung, P.-H.; Tsai, H.-B. ;Lai, M.-Y. ;Chen, P.-J. ;Chen, J.-H. ;Chen, D.-S. ;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; KAI-WEN HUANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:35:15Z |
DNA detection using commercial mobile phones
|
Chen, Ping Hei;Chen, Pei Jer;Yeh, Shiou Hwei;SHIOU-HWEI YEH;Chou, Wen Pin;PING-HEI CHEN;Lee, Dasheng;PEI-JER CHEN;Chen, Ping Hei;Chen, Pei Jer;Yeh, Shiou Hwei;Chou, Wen Pin;Lee, Dasheng;Chen, P.H.;Chen, P.J.;Yeh, S.H.;Chou, W.P.;Lee, D.; Lee, D.; Chou, W.P.; Yeh, S.H.; Chen, P.J.; Chen, P.H.; Lee, Dasheng; Chou, Wen Pin; Yeh, Shiou Hwei; Chen, Pei Jer; Chen, Ping Hei; PEI-JER CHEN; Lee, Dasheng; PING-HEI CHEN; Chou, Wen Pin; SHIOU-HWEI YEH; Yeh, Shiou Hwei; Chen, Pei Jer; Chen, Ping Hei |
| 臺大學術典藏 |
2018-09-10T08:32:51Z |
Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development
|
HSIANG-PO HUANG; PEI-JER CHEN; YUNG-MING JENG; KUN-HUEI YEH; DING-SHINN CHEN; SHIOU-HWEI YEH |
| 臺大學術典藏 |
2018-09-10T08:31:41Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng, T.-C. ;Yu, M.-L.; Liu, C.-J.; Lin, C.-L. ;Huang, Y.-W.; Hsu, C.-S.; Liu, C.-H.; Kuo, S.F.-T. ;Pan, C.J.-H. ;Yang, S.-S. ;Su, C.-W. ;Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:08Z |
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:08Z |
HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen, K.-F. Yu, H.-C. Liu, C.-Y. Chen, H.-J. Chen, Y.-C. Hou, D.-R. Chen, P.-J. Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan
|
Huang, Y.-W.;Liao, Y.-T.;Chen, W.;Chen, C.-L.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:40Z |
Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects
|
Kao, J.-H.;Chen, P.-J.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:39Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu, C.-S.; Wang, C.-C.;Wang, P.-C.; Lin, H.H.; Tseng, T.-C.; Chen, C.-H.; Su, W.-C.; Liu, C.-J.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:48Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata, M.;Lesmana, L.A.;Tateishi, R.;Chen, P.-J.;Lin, S.-M.;Yoshida, H.;Kudo, M.;Lee, J.M.;Choi, B.I.;Poon, R.T.P.;Shiina, S.;Cheng, A.L.;Jia, J.-D.;Obi, S.;Han, K.H.;Jafri, W.;Chow, P.;Lim, S.G.;Chawla, Y.K.;Budihusodo, U.;Gani, R.A.;Lesmana, C.R.;Putranto, T.A.;Liaw, Y.F.;Sarin, S.K.; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:47Z |
Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model
|
Huang, K.-W. and Wu, H.-L. and Lin, H.-L. and Liang, P.-C. and Chen, P.-J. and Chen, S.-H. and Lee, H.-I. and Su, P.-Y. and Wu, W.-H. and Lee, P.-H. and Hwang, L.-H. and Chen, D.-S.; PO-HUANG LEE; PO-CHIN LIANG; PEI-JER CHEN; DING-SHINN CHEN; KAI-WEN HUANG |
| 臺大學術典藏 |
2018-09-10T08:13:47Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S. and Liu, C.-H. and Liu, C.-J. and Hsu, S.-J. and Chen, C.-L. and Hwang, J.-J. and Lai, M.-Y. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; JUEY-JEN HWANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:44Z |
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
|
Su, T.-H. and Hsu, C.-S. and Chen, C.-L. and Liu, C.-H. and Huang, Y.-W. and Tseng, T.-C. and Liu, C.-J. and Chen, P.-J. and Lai, M.-Y. and Chen, D.-S. and Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Hsu, S.-J.;Lin, J.-W.;Chen, S.-I.;Hung, P.-H.;Tsai, H.-B.;Lai, M.-Y.;Chen, P.-J.;Chen, J.-H.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
|
Chen, K.-F.;Yu, H.-C.;Liu, T.-H.;Lee, S.-S.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG; SHOEI-SHENG LEE |
| 臺大學術典藏 |
2018-09-10T08:04:10Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu, M.-L. and Lee, C.-M. and Chuang, W.-L. and Lu, S.-N. and Dai, C.-Y. and Huang, J.-F. and Lin, Z.-Y. and Hu, T.-I. and Chen, C.-H. and Hung, C.-. and Wang, J.-H. and Chen, C.-L. and Kao, J.-H. and Lai, M.-Y. and Liu, C.-H. and Su, T.-H. and Wu, S.-S. and Liao, L.-Y. and Kuo, H.-T. and Chao, Y.-C. and Tung, S.-Y. and Yang, S.-S. and Chen, P.-J. and Liu, C.-J. and Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:05Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
|
Chun-Jen Liu;Pei-Jer Chen;Hung-Bin Tsai;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:03Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
|
Liu, C.-J.; Kao, J.-H.; Lai, M.-Y.; Chen, P.-J.; Chu, J.-S.; Chen, W.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:33Z |
Comparison of two methods for quantification of hepatitis B viral DNA
|
Kao, J.-H.; Wood, M.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu, Chun-Jen;Chuang, Wan-Long;Lee, Chuan-Mo;Yu, Ming-Lung;Lu, Sheng-Nan;Wu, Shun-Sheng;Chen, Chi-Ling;Yang, Sien-Sing;Kao, Jia-Horng;Liu, Chen-Hua;Su, Wei-Wen;Jeng, Yung-Ming;Chen, Pei-Jer;Chen, Ding-Shinn; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway
|
Chou, C.H. and Chen, P.-J. and Jeng, Y.-M. and Cheng, A.-L. and Huang, L.-R. and Cheng, J.C.-H.; YUNG-MING JENG; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:35:35Z |
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study
|
Shih, W.-L. and Yu, M.-W. and Chen, P.-J. and Wu, T.-W. and Lin, C.-L. and Liu, C.-J. and Lin, S.-M. and Tai, D.-I. and Lee, S.-D. and Liaw, Y.-F.; 施惟量;于明暉;陳培哲;吳泰瑋;林志陵;劉俊人;林錫銘;戴達英;李壽東;廖運範; SHIH, WEI-LIANG;YU, MING-WHEI;CHEN, PEI -JER;WU, TAI-WEI;LIN, CHIH-LIN;LIU, CHUN-JEN;LIN, SHI-MING;TAI, DAR-IN;LEE, SHOU-DONG;LIAW, YUN-FAN; MING-WHEI YU; CHUN-JEN LIU; PEI-JER CHEN; YU, MING-WHEI; WU, TAI-WEI; LIN, CHIH-LIN; LIU, CHUN-JEN; LIN, SHI-MING; TAI, DAR-IN; LEE, SHOU-DONG; LIAW, YUN-FAN |
| 臺大學術典藏 |
2018-09-10T07:35:35Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:34Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
Liu, Chun-Jen;Jeng, Yung-Ming;Chen, Chi-Ling;Chen, Pei-Jer;Chen, Ting-Chi;Liu, Chen-Hua;Lai, Ming-Yang;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; PEI-JER CHEN; YUNG-MING JENG; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; JENG, YUNG-MING; CHEN, CHI-LING; CHEN, PEI-JER; CHEN, TING-CHI; LIU, CHEN-HUA; LAI, MING-YANG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus
|
PEI-JER CHEN; CHUNG-YI HU; DING-SHINN CHEN; JIA-HORNG KAO; HUANG, YI-WEN; HU, CHUNG-YI; CHEN, CHI-LING; LIAO, YA-TANG; LIU, CHUN-JEN; LAI, MING-YANG; CHEN, PEI-JER; YANG, SIEN-SING; HU, JUI-TING; CHEN, DING-SHINN; KAO, JIA-HORNG; CHUN-JEN LIU; Huang, Yi-Wen;Hu, Chung-Yi;Chen, Chi-Ling;Liao, Ya-Tang;Liu, Chun-Jen;Lai, Ming-Yang;Chen, Pei-Jer;Yang, Sien-Sing;Hu, Jui-Ting;Chen, Ding-Shinn;Kao, Jia-Horng; YI-WEN HUANG |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection
|
Liu, Chun-Jen;Chen, Pei-Jer;Lai, Ming-Yang;Liu, Chen-Hua;Chen, Chi-Ling;Kao, Jia-Horng;Chen, Ding-Shinn; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHEN, PEI-JER; LAI, MING-YANG; LIU, CHEN-HUA; CHEN, CHI-LING; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 臺大學術典藏 |
2018-09-10T07:06:12Z |
Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone
|
Kao, J.-H.; Lai, M.-Y.; Chen, W.; Chen, P.-J.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:33Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu, C.-S.;Liu, C.-J.;Liu, C.-H.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:52:13Z |
Precore stop codon mutant in chronic hepatitis B virus infection in children: Its relation to hepatitis B e seroconversion and maternal hepatitis B surface antigen
|
Chang, M.-H. and Hsu, H.-Y. and Ni, Y.-H. and Tsai, K.-S. and Lee, P.-I. and Chen, P.-J. and Hsu, Y.-L. and Chen, D.-S.; HONG-YUAN HSU; PING-ING LEE; KEH-SUNG TSAI; MEI-HWEI CHANG; PEI-JER CHEN; DING-SHINN CHEN; Yen-Hsuan Ni |
| 臺大學術典藏 |
2018-09-10T06:49:56Z |
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization
|
PEI-JER CHEN; LI-MIN HUANG; CHUN-YI LU; CHIN-YUN LEE; DING-SHINN CHEN; Yen-Hsuan Ni; Lu, C.-Y. and Ni, Y.-H. and Chiang, B.-L. and Chen, P.-J. and Chang, M.-H. and Chang, L.-Y. and Su, I.-J. and Kuo, H.-S. and Huang, L.-M. and Chen, D.-S. and Lee, C.-Y.; BOR-LUEN CHIANG; LUAN-YIN CHANG; MEI-HWEI CHANG |
| 臺大學術典藏 |
2018-09-10T06:41:18Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
|
Wang-Huei Sheng; Jia-Horng Kao; Pei-Jer Chen; Li-Ming Huang; Sui-Yuan Chang; Hsin-Yun Sun; Chien-Ching Hung; Mao-Yuan Chen; Shan-Chwen Chang; LI-MIN HUANG |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users
|
PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; Lai, MY; JIA-HORNG KAO; Chen, DS; Kao, JH.; Lin, C.-.;Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; Lin, CL; Liu, CJ |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan
|
Tseng, T.-C.; Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Lin, C.-L.; Kao, J.-K.; Chen, D.-S.; CHUN-JEN LIU; Tseng, TC; Liu, CJ; PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; JIA-HORNG KAO; Lai, MY; Lin, CL; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan
|
Shao, Yu-Yun; Liu, CJ; PEI-JER CHEN; Lai, MY; DING-SHINN CHEN; Lee, Yi-Hsuan; Hsieh, Min-Shu; JIA-HORNG KAO; Chen, PJ; Kao, JH; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Chen, DS.; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒; Hsu, CS; Hsu, C.-S.; Liu, C.-J.; Lai, M.-Y.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; Lu, Li-Chun; CHUN-JEN LIU |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels
|
Lin, Chih-Lin; Liao, Li-Ying; Liu, Chun-Jen; Yu, Ming-Whei; Chen, Pei-Jer; Lai, Ming-Yang; Chen, Ding-Shinn; Kao, Jia-Horng; Lin, Chih-Lin; MING-WHEI YU; Lin, CL; Liao, LY; Liao, Li-Ying; CHUN-JEN LIU; Liu, CJ; PEI-JER CHEN; Liu, Chun-Jen; Kao, Jia-Horng; Kao, JH.; Chen, Ding-Shinn; Chen, DS; Lai, Ming-Yang; Lai, MY; Chen, Pei-Jer; Chen, PJ; JIA-HORNG KAO; DING-SHINN CHEN; Yu, MW; Yu, Ming-Whei |
| 臺大學術典藏 |
2018-09-10T06:33:01Z |
Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma
|
Lin, C.-L.; Liu, C.-H.; Chen, W.; Huang, W.-L.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H.; Lin, CL; PEI-JER CHEN; CHEN-HUA LIU; Liu, CH; DING-SHINN CHEN; Chen, W; JIA-HORNG KAO; Huang, WL; Chen, PJ; Lai, MY; Chen, DS; Kao, JH. |
顯示項目 751-800 / 883 (共18頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目
|
